设为首页 加入收藏

TOP

Peyona(Caffeine Citrate Injection)(五)
2013-06-17 12:31:55 来源: 作者: 【 】 浏览:8260次 评论:0
s on the cardio-respiratory and central nervous system. If concurrent use is indicated, cardiac rhythm and blood pressure must be carefully monitored.
4.6 Pregnancy and lactation
Caffeine in animal studies, at high doses, was shown to be embryotoxic and teratogenic. These effects are not relevant with regard to short term administration in the preterm infant population (see section 5.3).
Caffeine is excreted into breast milk and readily crosses the placenta into the foetal circulation (see section 5.2).
Breast-feeding mothers of neonates treated with caffeine citrate should not ingest caffeine-containing foods, beverages or medicinal products containing caffeine.
In neonates born to mothers who consumed large quantities of caffeine prior to delivery, baseline plasma caffeine concentrations should be measured prior to initiation of treatment with caffeine citrate (see section 4.4).
4.7 Effects on ability to drive and use machines
Not relevant.
4.8 Undesirable effects
The known pharmacology and toxicology of caffeine and other methylxanthines predict the likely adverse reactions to caffeine citrate. Effects described include central nervous system (CNS) stimulation such as irritability, restlessness and jitteriness, and cardiac effects such as tachycardia, hypertension and increased stroke volume. These effects are dose related and may necessitate measurement of plasma levels and dose reduction.
The adverse reactions described in the short- and long-term published literature that can be associated with caffeine citrate are listed below by System Organ Class and Preferred Term (MedDRA).
Frequency is defined as: very common (≥ 1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
 

System Organ Class

Adverse Reaction

Frequency

Infections and infestations

Sepsis

Not known

Immune system disorders

Hypersensitivity reaction

Rare

Metabolism and nutrition disorders

Hypoglycaemia, hyperglycaemia, failure to thrive, feeding intolerance

Not known

Nervous system disorders

Irritability, jitteriness, restlessness, brain injury*, convulsion*

Not known

Ear and labyrinth disorders

Deafness*

Not known

Cardiac disorders

Tachycardia, also associated with increased left ventricular output and increased stroke volume

Not known

Gastrointestinal disorders

Regurgitation, increased gastric aspirate, necrotising enterocolitis**

Not known

General disorders and administration site conditions

Infusion site phlebitis, infusion site inflammation

Common

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 2 3 4 5 6 7 8 下一页 尾页 5/9/9
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Peyona(Caffeine Citrate Inject.. 下一篇Renvela (sevelamer carbonate)

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位